BBAI
BigBear.ai Holdings Inc
-61.99%
$4.92 - $1.87
Feb 7th 2023 - Mar 21st 2023
Feb, 12, 2023
$IVDA is diverse in its revenue streams, Ivedacare... See more
Jan, 31, 2023
Hot sector, a turnaround story with expanding prod... See more
GS
Goldman Sachs Group, Inc.
-15.26%
$374.40 - $317.28
Feb 7th 2023 - Mar 21st 2023
BXRX
Baudax Bio Inc
-52.79%
$3.41 - $1.61
Feb 7th 2023 - Mar 21st 2023
Nov, 29, 2022
$BXRX Even if they don't sell Anjeso, the prod... See more
Nov, 5, 2022
$EMED QB ticker announced new product , .01-.03 n... See more
Feb, 12, 2023
$IVDA is diverse in its revenue streams, Ivedacare as a product line for $BBAI $SOUN $AI $FOXO would be far superior to any of their AI components,
Jan, 31, 2023
Hot sector, a turnaround story with expanding product range, tested and liked by US Army, partnerships with global leaders in their fields like Redwire and Palantir, what's not to like?
Jan, 30, 2023
$AAPL earnings are not gonna be too strong if we base it of $GS data and sales data for product lines still great company
Nov, 29, 2022
$BXRX Even if they don't sell Anjeso, the product is unique in a market with great potential.
Nov, 5, 2022
$EMED QB ticker announced new product , .01-.03 nice % incoming i believe
Oct, 11, 2022
$BXRX THE COMPANY HAS AN EXCELLENT PRODUCT MILOXICAM IV FOR PAIN RELIEF.
Oct, 7, 2022
A unique product on the market that will soon be marketed internationally as well.